SIO 2020 Virtual Conference is October 16-17, 2020

Registration is open!

Please visit our Conference Home Page for more information and to register.

 

SIO Offers Membership Scholarship

SIO is pleased to offer 2020 membership scholarships for patient advocates, trainees and students. Please access the application and send to: info@integrativeonc.org

 

18th International Conference Rescheduled to September 24-26, 2021 

Read letter from SIO President, Ting Bao, MD, DABMA, MS.

 

SIO Abstract Submissions Portal Will Re-Open in Early 2021

Due to the 17th International Conference being postponed until September 24-26, 2021, we have closed the abstract submisssions portal. Please watch for notifications of its re-opening in early 2021. All abstracts that have been submitted to date will be saved and submitted to the review committee. 

 


Image1

Clinical Practice Guidelines

SIO is pleased to provide its updated clinical practice guidelines for breast cancer. In June 2018, ASCO announced endorsement of the guidelines. The guidelines were published in 2017. Researchers analyzed which integrative treatments are most effective and safe for patients with breast cancer. The guidelines are a resource for clinicians and patients to inform evidence-based decisions on the use of integrative therapies during breast cancer treatment. Researchers at US and Canadian institutions evaluated the efficacy and safety of more than 80 therapies.

The Journal of the National Cancer Institute Monograph has  published a special issue co-sponsored by SIO, "Advancing the Global Impact of Integrative Oncology"; including a comprehensive definition for integrative oncology. The articles in the special Monograph were all peer-reviewed.


                                                                    

Navajo Nation's Regional Healthcare Facility Needs Our Help

The current COVID-19 pandemic has acutely affected the Navajo Nation, which lives in a region spanning parts of Arizona, Utah and New Mexico. Historically, the Navajo People have suffered high rates of diabetes, cardiovascular disease and cancer, all of which contribute to increased risk for poorer COVID-19 outcomes.

For decades, tribal land has been left without basic infrastructure such as running water, electricity and paved roads.

The Indian Health Service has been chronically underfunded, and the Tuba City Regional Healthcare Corporation is the only cancer treatment location on any Native American soil. The SIO is honored to present this support initiative. Donations will go directly to Tuba City Regional Healthcare through the Cancer Support Community donation page, and will be used for essential healthcare needs such as PPE for staff and hand sanitizer. Please join us in this opportunity to improve the lives of those who suffer such health disparities. Learn  more on our COVID-19 Resources page and submit your contribution on our Donation page.

SIO Wellness Wednesdays

SIO's special summer program, Wellness Wednesdays, is in full swing and runs through Labor Day. Developed by SIO's Yoga SIG, it features a live panel discussion and interactive audience dialogue each Wednesday at 12:00 pm ET on Zoom. Following the program, attendees may view a recorded session on SIO's YouTube channel focusing on the topic of the week. If you were unable to attend earlier episodes or view the videos, check them out on SIO's YouTube channel.

Read the latest blog from Eugene  and Linda Carlson, PhD, C.Psych 
"What Now? Navigating cancer treatment during a possible COVID-19 'second wave'"

"The Use of Traditional Chinese Herbal Medicine in COVID-19 - Where's the Evidence?"

Webinar presentation by Weidong Lu, MB, MPH, PhD, Dana-Farber Cancer Institute - recording now available on YouTube.

TCM and Integrative Oncology Practice in China During COVID-19 Outbreak

by Yufei Yang, MD 

Given the rapidly progressing global COVID-19 crisis, SIO leadership has decided to launch a COVID-19 column to specifically address our members’ needs. Our first interview is with Yufei Yang, MD, who is the director of integrative oncology at Beijing Xiyuan Hospital. We would like to learn from our Chinese colleagues’ recent advances in combating COVID-19. This is in keeping with SIO’s practice of facilitating opportunities to share our members’ experiences and perspectives. The full article - TCM and Integrative Oncology Practice in China During COVID-19 Outbreak represents Dr. Yang and her team’s views only.

 

Call for Applications: SIO 2020 Africa Travel Scholarship - Postponed Until 2021

Please watch for details in early 2021.

 

Watch Video on Abstract Writing Best Practices 

Please be sure to watch this video in preparation for submitting abstracts in early 2021.

 

SIO 2019 Conference Presentations Available on VuMedi

As a resource to SIO conference attendees, presentations from SIO's 16th International Conference in NYC are now accessible through VuMedi.com, a video hosting platform that posts content from a broad range of healthcare organizations and medical professionals.

The SIO Clinical Practice Guidelines are referenced in MedLine and are posted on the National Institutes of Health National Center for Complementary and Integrative Health website https://nccih.nih.gov/health/providers/clinicalpractice.htm. The SIO Clinical Practice Guidelines are the only comprehensive evidence-based guidelines for incorporating complementary and integrative therapies into conventional oncology clinical practice. The published guidelines are available for FREE.

 April 2017 Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

2014 SIO Guidelines, Clinical Practice Guidelines on the Use of Integrative Therapies as Supportive Care in Patients Treated for Breast Cancer as Supportive Care in Patients Treated for Breast Cancer.

2013 SIO Guidelines, Complementary therapies and integrative medicine in lung cancer: Diagnosis and Management of Lung Cancer.

2009 SIO Guidelines, Evidence-Based Clinical Practice Guidelines for Integrative Oncology: Complementary Therapies and Botanicals.

Visit the NCCIH website for more information.

Read the press release announcing the publication of the 2014 Clinical Practice Guidelines on the Use of Integrative Therapies as Supportive Care in Patients Treated for Breast Cancer

History of SIO Clinical Practice Guidelines

The Society for Integrative Oncology (SIO) published its first edition of Integrative Oncology Practice Guidelines in 2007.1 Experts who specialize in defined categories of integrative or complementary therapies were asked to review the scientific literature and categorize the interventions into specific levels of utility that take into account the methodological strength of supportive evidence, benefits versus risks, practicality, and value. Members of the SIO Executive Committee, who are responsible for the final recommendations, peer reviewed and critiqued the submissions, with the final product a consensus. The 2009 edition2 updates and expands on the previous version and provides practical recommendations for the use of complementary therapies in the supportive care of cancer patients.

In pdf 2007 (263 KB)  and then again in 2013, SIO published guidelines in Chest on the use of Complementary Therapies and Integrative Oncology in Lung Cancer. 3,4

In 2014, SIO published the Clinical Practice Guidelines on the Use of Integrative Therapies as Supportive Care in Patients Treated for Breast Cancer in the Journal of the National Cancer Institute Monograph Special Issue on Integrative Oncology.

 

The guidelines are not intended to remove the freedom of individual decision making, and the authors emphasize the importance of having degrees of freedom. It is useful, however, for clinicians to refer to these guidelines when making clinical choices with their patients. They will also be useful for quality assurance, clinical governance, and medical legislation and will provide indications for reimbursement that add value to clinical programs. They clearly illustrate the importance of multidisciplinary health care teams that jointly use their skills based on the expanding evidence base for integrative medicine. We hope that the guidelines will prevent inappropriate variation in clinical practice and underline the professional basis for integrative medicine. As such, this will provide a useful resource for all clinicians as well as administrators. So, why publish guidelines? These are tools, not rules. We need to formulate clinical decision making that is based on the best research evidence available, based on knowledge of relative safety and possible adverse effects, and that is economical compared with other interventions. One of the tenets of integrative oncology is to involve patients in the decision-making process, so we place emphasis on the clinical encounter and the safe integration of combined modalities that suit the patient's culture and belief system. However, economics includes not only financial costs but also the cost of missed opportunities and adverse events. It is imperative that all practitioners concerned for cancer patients have the knowledge and skills to design personalized programs that wisely support patients through their anticancer therapies. The consultation is an opportunity for education and must include clear guidance as to what is complementary and what is deemed alternative and, therefore, by definition, should be avoided. The guidelines clearly advocate evidence-based complementary therapies that support patients through their standard anticancer treatment, help reduce adverse effects, and improve their quality of life.

We are hopeful that the research will eventually show that using these evidence-based guidelines for integrative oncology will have economic advantages by supporting patients through their anticancer treatment, by teaching improved coping skills, by encouraging more rapid rehabilitation, and by teaching tertiary prevention strategies. By standardizing these approaches, we will be able to collect high-quality data that can be used to compare programs in various institutions and implement quality assurance.

References

1. Deng GE, Cassileth BR, Cohen L, Gubili J, Johnstone PA, Kumar N, Vickers A. Integrative oncology practice guidelines. J Soc Integr Oncol 2007; 5: 65 – 84.

2. Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, Courneya KS, Dryden T, Hanser S, Kumar N, Labriola D, Wardell DW, Sagar S. Evidence-Based Clinical Practice Guidelines for Integrative Oncology: Complementary Therapies and Botanicals. Journal of the Society for Integrative Oncology, Vol 7, No 3 (Summer), 2009: pp 85–120.

3. Cassileth BR, Deng GE, Gomez JE, Johnstone PA, Kumar N, Vickers AJ. Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):340s-354s.

4. Deng GE, Rausch SM, Jones LW, Gulati A, Kumar NB, Greenlee H, Pietanza MC, Cassileth BR. Complementary therapies and integrative medicine in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl):e420S-36S.

5. Greenlee H, Balneaves L, Carlson LE, Cohen M, Deng G, Hershman D, Mumber M, Perlmutter J, Seely D, Sen A, Zick SM, Tripathy D. Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monograph. 2014;50:346-358.

@Integrativeonc

  • As promised, here's the link to register for #WellnessWednesdays Episode 10 on Aug. 12 - be sure to register early!…
    https://t.co/7KfpJPpRUK

  • The latest episode of SIO's Educational Webinar Series is now available on SIO's YouTube Channel- "Natural Products…
    https://t.co/zHjfhTo8eH

  • You still have time to register for SIO's Summer Wellness Wednesdays - Episode 9! Today at 12:00 pm ET A Family Ap…
    https://t.co/IW755e1cO2